![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | PDZD2 | Human | (-)-epigallocatechin 3-gallate | increases expression | EXP | | 6480464 | epigallocatechin gallate results in increased expression of PDZD2 protein | CTD | PMID:31195006 | PDZD2 | Human | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Progesterone] results in increased expression of PDZD2 mRNA and [Progesterone co-treated with Estradiol] results in increased expression of PDZD2 mRNA | CTD | PMID:17404688 and PMID:20660070 | PDZD2 | Human | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Pdzd2 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:31388691 | PDZD2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Pdzd2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PDZD2 mRNA | CTD | PMID:19933214 | PDZD2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Pdzd2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PDZD2 mRNA | CTD | PMID:33387578 | PDZD2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases methylation | ISO | Pdzd2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased methylation of PDZD2 gene | CTD | PMID:21212295 | PDZD2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Pdzd2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of PDZD2 gene | CTD | PMID:21212295 | PDZD2 | Human | 2,6-dinitrotoluene | affects expression | ISO | Pdzd2 (Rattus norvegicus) | 6480464 | 2 and 6-dinitrotoluene affects the expression of PDZD2 mRNA | CTD | PMID:21346803 | PDZD2 | Human | 2-hydroxypropanoic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of PDZD2 mRNA | CTD | PMID:30851411 | PDZD2 | Human | 3,3',4,4',5-pentachlorobiphenyl | decreases expression | ISO | Pdzd2 (Rattus norvegicus) | 6480464 | 3 more ... | CTD | PMID:23196670 | PDZD2 | Human | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Pdzd2 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of PDZD2 mRNA | CTD | PMID:20188158 | PDZD2 | Human | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Pdzd2 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of PDZD2 mRNA | CTD | PMID:26251327 | PDZD2 | Human | 3,4-methylenedioxymethamphetamine | increases methylation | ISO | Pdzd2 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased methylation of PDZD2 promoter | CTD | PMID:26251327 | PDZD2 | Human | 4,4'-sulfonyldiphenol | increases methylation | ISO | Pdzd2 (Mus musculus) | 6480464 | bisphenol S results in increased methylation of PDZD2 exon | CTD | PMID:33297965 | PDZD2 | Human | 4-hydroxyphenyl retinamide | decreases expression | ISO | Pdzd2 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of PDZD2 mRNA | CTD | PMID:28973697 | PDZD2 | Human | 4-hydroxyphenyl retinamide | increases expression | ISO | Pdzd2 (Mus musculus) | 6480464 | Fenretinide results in increased expression of PDZD2 mRNA | CTD | PMID:28973697 | PDZD2 | Human | 6-propyl-2-thiouracil | decreases expression | ISO | Pdzd2 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of PDZD2 mRNA | CTD | PMID:30047161 | PDZD2 | Human | acrylamide | decreases expression | ISO | Pdzd2 (Rattus norvegicus) | 6480464 | Acrylamide results in decreased expression of PDZD2 mRNA | CTD | PMID:28959563 | PDZD2 | Human | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of PDZD2 mRNA | CTD | PMID:32763439 | PDZD2 | Human | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of PDZD2 intron | CTD | PMID:30157460 | PDZD2 | Human | Aflatoxin B2 alpha | decreases methylation | EXP | | 6480464 | aflatoxin B2 results in decreased methylation of PDZD2 intron | CTD | PMID:30157460 | PDZD2 | Human | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of PDZD2 mRNA | CTD | PMID:21934132 | PDZD2 | Human | amitrole | decreases expression | ISO | Pdzd2 (Rattus norvegicus) | 6480464 | Amitrole results in decreased expression of PDZD2 mRNA | CTD | PMID:30047161 | PDZD2 | Human | ammonium chloride | affects expression | ISO | Pdzd2 (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of PDZD2 mRNA | CTD | PMID:16483693 | PDZD2 | Human | antirheumatic drug | increases expression | EXP | | 6480464 | Antirheumatic Agents results in increased expression of PDZD2 mRNA | CTD | PMID:24449571 | PDZD2 | Human | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of PDZD2 mRNA | CTD | PMID:33212167 | PDZD2 | Human | arsane | multiple interactions | EXP | | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of PDZD2 mRNA | CTD | PMID:32525701 | PDZD2 | Human | arsane | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of PDZD2 gene | CTD | PMID:25304211 | PDZD2 | Human | arsenic atom | multiple interactions | EXP | | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of PDZD2 mRNA | CTD | PMID:32525701 | PDZD2 | Human | arsenic atom | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of PDZD2 gene | CTD | PMID:25304211 | PDZD2 | Human | arsenite(3-) | multiple interactions | EXP | | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to PDZD2 mRNA] | CTD | PMID:32406909 | PDZD2 | Human | arsenous acid | decreases expression | EXP | | 6480464 | Arsenic Trioxide results in decreased expression of PDZD2 mRNA | CTD | PMID:15761015 | PDZD2 | Human | atrazine | decreases expression | ISO | Pdzd2 (Rattus norvegicus) | 6480464 | Atrazine results in decreased expression of PDZD2 mRNA | CTD | PMID:36841081 | PDZD2 | Human | atrazine | affects methylation | ISO | Pdzd2 (Rattus norvegicus) | 6480464 | Atrazine affects the methylation of PDZD2 gene | CTD | PMID:35440735 | PDZD2 | Human | azoxystrobin | multiple interactions | ISO | Pdzd2 (Rattus norvegicus) | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of PDZD2 gene | CTD | PMID:33854195 | PDZD2 | Human | benzo[a]pyrene | increases expression | ISO | Pdzd2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of PDZD2 mRNA | CTD | PMID:27195522 | PDZD2 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of PDZD2 intron and Benzo(a)pyrene affects the methylation of PDZD2 promoter | CTD | PMID:27901495 and PMID:30157460 | PDZD2 | Human | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:19150397 | PDZD2 | Human | benzo[e]pyrene | increases methylation | EXP | | 6480464 | benzo(e)pyrene results in increased methylation of PDZD2 intron | CTD | PMID:30157460 | PDZD2 | Human | bis(2-ethylhexyl) phthalate | decreases expression | ISO | Pdzd2 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in decreased expression of PDZD2 mRNA | CTD | PMID:33754040 | PDZD2 | Human | bisphenol A | affects expression | ISO | Pdzd2 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of PDZD2 mRNA | CTD | PMID:25181051 | PDZD2 | Human | bisphenol A | increases expression | ISO | Pdzd2 (Mus musculus) | 6480464 | bisphenol A results in increased expression of PDZD2 mRNA | CTD | PMID:32156529 and PMID:35598803 | PDZD2 | Human | bisphenol A | decreases methylation | EXP | | 6480464 | bisphenol A results in decreased methylation of PDZD2 gene | CTD | PMID:31601247 | PDZD2 | Human | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of PDZD2 gene | CTD | PMID:31601247 | PDZD2 | Human | bisphenol A | decreases expression | ISO | Pdzd2 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of PDZD2 mRNA | CTD | PMID:30816183 | PDZD2 | Human | bisphenol A | increases methylation | ISO | Pdzd2 (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of PDZD2 gene | CTD | PMID:28505145 | PDZD2 | Human | C60 fullerene | increases expression | ISO | Pdzd2 (Rattus norvegicus) | 6480464 | fullerene C60 results in increased expression of PDZD2 mRNA | CTD | PMID:19167457 | PDZD2 | Human | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of PDZD2 mRNA | CTD | PMID:38382870 | PDZD2 | Human | calcitriol | increases expression | EXP | | 6480464 | Calcitriol results in increased expression of PDZD2 mRNA | CTD | PMID:16002434 | PDZD2 | Human | capsaicin | increases expression | ISO | Pdzd2 (Rattus norvegicus) | 6480464 | Capsaicin results in increased expression of PDZD2 mRNA | CTD | PMID:16278290 | PDZD2 | Human | carbon nanotube | decreases expression | ISO | Pdzd2 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | PDZD2 | Human | chlorpyrifos | multiple interactions | ISO | Pdzd2 (Rattus norvegicus) | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of PDZD2 gene | CTD | PMID:33854195 | PDZD2 | Human | crocidolite asbestos | decreases expression | ISO | Pdzd2 (Mus musculus) | 6480464 | Asbestos and Crocidolite results in decreased expression of PDZD2 mRNA | CTD | PMID:29279043 | PDZD2 | Human | cumene | decreases expression | ISO | Pdzd2 (Mus musculus) | 6480464 | cumene results in decreased expression of PDZD2 mRNA | CTD | PMID:18648096 | PDZD2 | Human | diarsenic trioxide | decreases expression | EXP | | 6480464 | Arsenic Trioxide results in decreased expression of PDZD2 mRNA | CTD | PMID:15761015 | PDZD2 | Human | Dibutyl phosphate | affects expression | EXP | | 6480464 | di-n-butylphosphoric acid affects the expression of PDZD2 mRNA | CTD | PMID:37042841 | PDZD2 | Human | dibutyl phthalate | decreases expression | ISO | Pdzd2 (Rattus norvegicus) | 6480464 | Dibutyl Phthalate results in decreased expression of PDZD2 mRNA | CTD | PMID:21266533 | PDZD2 | Human | dioxygen | increases expression | EXP | | 6480464 | Oxygen deficiency results in increased expression of PDZD2 mRNA | CTD | PMID:26516004 | PDZD2 | Human | dioxygen | multiple interactions | ISO | Pdzd2 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PDZD2 mRNA | CTD | PMID:30529165 | PDZD2 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PDZD2 mRNA | CTD | PMID:27188386 | PDZD2 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of PDZD2 mRNA | CTD | PMID:29803840 | PDZD2 | Human | endosulfan | decreases expression | ISO | Pdzd2 (Rattus norvegicus) | 6480464 | Endosulfan results in decreased expression of PDZD2 mRNA | CTD | PMID:29391264 | PDZD2 | Human | ethanol | affects expression | ISO | Pdzd2 (Mus musculus) | 6480464 | Ethanol affects the expression of PDZD2 mRNA | CTD | PMID:30319688 | PDZD2 | Human | flavonoids | increases expression | ISO | Pdzd2 (Rattus norvegicus) | 6480464 | Flavonoids results in increased expression of PDZD2 mRNA | CTD | PMID:18035473 | PDZD2 | Human | folic acid | decreases expression | ISO | Pdzd2 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of PDZD2 mRNA | CTD | PMID:25629700 | PDZD2 | Human | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of PDZD2 gene | CTD | PMID:31601247 | PDZD2 | Human | gentamycin | decreases expression | ISO | Pdzd2 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of PDZD2 mRNA | CTD | PMID:33387578 | PDZD2 | Human | glyphosate | multiple interactions | ISO | Pdzd2 (Rattus norvegicus) | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of PDZD2 gene | CTD | PMID:33854195 | PDZD2 | Human | GW 4064 | increases expression | ISO | Pdzd2 (Mus musculus) | 6480464 | GW 4064 results in increased expression of PDZD2 mRNA | CTD | PMID:26655953 | PDZD2 | Human | imidacloprid | multiple interactions | ISO | Pdzd2 (Rattus norvegicus) | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of PDZD2 gene | CTD | PMID:33854195 | PDZD2 | Human | Indeno[1,2,3-cd]pyrene | decreases expression | ISO | Pdzd2 (Mus musculus) | 6480464 | indeno(1 more ... | CTD | PMID:26377693 | PDZD2 | Human | lipopolysaccharide | decreases methylation | ISO | Pdzd2 (Mus musculus) | 6480464 | Lipopolysaccharides results in decreased methylation of PDZD2 gene | CTD | PMID:21212295 | PDZD2 | Human | lipopolysaccharide | increases expression | EXP | | 6480464 | Lipopolysaccharides results in increased expression of PDZD2 mRNA | CTD | PMID:35811015 | PDZD2 | Human | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PDZD2 mRNA | CTD | PMID:35811015 | PDZD2 | Human | lipopolysaccharide | multiple interactions | ISO | Pdzd2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of PDZD2 gene | CTD | PMID:21212295 | PDZD2 | Human | maneb | multiple interactions | ISO | Pdzd2 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of PDZD2 mRNA | CTD | PMID:36117858 | PDZD2 | Human | mercury dichloride | decreases expression | ISO | Pdzd2 (Rattus norvegicus) | 6480464 | Mercuric Chloride results in decreased expression of PDZD2 mRNA | CTD | PMID:16507785 | PDZD2 | Human | methapyrilene | increases methylation | EXP | | 6480464 | Methapyrilene results in increased methylation of PDZD2 intron | CTD | PMID:30157460 | PDZD2 | Human | methimazole | decreases expression | ISO | Pdzd2 (Rattus norvegicus) | 6480464 | Methimazole results in decreased expression of PDZD2 mRNA | CTD | PMID:30047161 | PDZD2 | Human | methoxychlor | affects methylation | ISO | Pdzd2 (Rattus norvegicus) | 6480464 | Methoxychlor affects the methylation of PDZD2 gene | CTD | PMID:35440735 | PDZD2 | Human | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of PDZD2 mRNA | CTD | PMID:28001369 | PDZD2 | Human | N,N-diethyl-m-toluamide | multiple interactions | ISO | Pdzd2 (Rattus norvegicus) | 6480464 | [Permethrin co-treated with DEET] results in increased methylation of PDZD2 gene | CTD | PMID:33148267 | PDZD2 | Human | nickel atom | decreases expression | EXP | | 6480464 | Nickel results in decreased expression of PDZD2 mRNA | CTD | PMID:24768652 and PMID:25583101 | PDZD2 | Human | nickel dichloride | increases expression | EXP | | 6480464 | nickel chloride results in increased expression of PDZD2 mRNA | CTD | PMID:17312168 | PDZD2 | Human | nickel sulfate | decreases expression | EXP | | 6480464 | nickel sulfate results in decreased expression of PDZD2 mRNA | CTD | PMID:22714537 | PDZD2 | Human | ozone | multiple interactions | ISO | Pdzd2 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PDZD2 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of PDZD2 mRNA | CTD | PMID:34911549 | PDZD2 | Human | p-chloromercuribenzoic acid | decreases expression | EXP | | 6480464 | p-Chloromercuribenzoic Acid results in decreased expression of PDZD2 mRNA | CTD | PMID:26272509 | PDZD2 | Human | p-chloromercuribenzoic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PDZD2 mRNA | CTD | PMID:27188386 | PDZD2 | Human | paracetamol | decreases expression | ISO | Pdzd2 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of PDZD2 mRNA | CTD | PMID:33387578 | PDZD2 | Human | paraquat | decreases expression | ISO | Pdzd2 (Rattus norvegicus) | 6480464 | Paraquat results in decreased expression of PDZD2 mRNA | CTD | PMID:32680482 | PDZD2 | Human | paraquat | multiple interactions | ISO | Pdzd2 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of PDZD2 mRNA | CTD | PMID:36117858 | PDZD2 | Human | permethrin | multiple interactions | ISO | Pdzd2 (Rattus norvegicus) | 6480464 | [Permethrin co-treated with DEET] results in increased methylation of PDZD2 gene | CTD | PMID:33148267 | PDZD2 | Human | potassium chromate | decreases expression | EXP | | 6480464 | potassium chromate(VI) results in decreased expression of PDZD2 mRNA | CTD | PMID:22714537 | PDZD2 | Human | progesterone | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Progesterone] results in increased expression of PDZD2 mRNA and [Progesterone co-treated with Estradiol] results in increased expression of PDZD2 mRNA | CTD | PMID:17404688 and PMID:20660070 | PDZD2 | Human | progesterone | increases expression | EXP | | 6480464 | Progesterone results in increased expression of PDZD2 mRNA | CTD | PMID:17404688 | PDZD2 | Human | rac-lactic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of PDZD2 mRNA | CTD | PMID:30851411 | PDZD2 | Human | S-(1,2-dichlorovinyl)-L-cysteine | decreases expression | EXP | | 6480464 | S-(1 and 2-dichlorovinyl)cysteine results in decreased expression of PDZD2 mRNA | CTD | PMID:33725128 | PDZD2 | Human | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PDZD2 mRNA | CTD | PMID:35811015 | PDZD2 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PDZD2 mRNA | CTD | PMID:27188386 | PDZD2 | Human | serpentine asbestos | decreases expression | EXP | | 6480464 | Asbestos and Serpentine results in decreased expression of PDZD2 mRNA | CTD | PMID:29523930 | PDZD2 | Human | sodium arsenate | multiple interactions | EXP | | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of PDZD2 mRNA | CTD | PMID:32525701 | PDZD2 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of PDZD2 mRNA | CTD | PMID:38568856 | PDZD2 | Human | sulforaphane | decreases expression | EXP | | 6480464 | sulforaphane results in decreased expression of PDZD2 mRNA | CTD | PMID:31838189 | PDZD2 | Human | tert-butyl hydroperoxide | decreases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in decreased expression of PDZD2 mRNA | CTD | PMID:15336504 | PDZD2 | Human | thiabendazole | multiple interactions | ISO | Pdzd2 (Rattus norvegicus) | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of PDZD2 gene | CTD | PMID:33854195 | PDZD2 | Human | thiram | decreases expression | EXP | | 6480464 | Thiram results in decreased expression of PDZD2 mRNA | CTD | PMID:38568856 | PDZD2 | Human | titanium dioxide | affects expression | ISO | Pdzd2 (Mus musculus) | 6480464 | titanium dioxide affects the expression of PDZD2 mRNA | CTD | PMID:17656681 | PDZD2 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of PDZD2 mRNA | CTD | PMID:37042841 | PDZD2 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of PDZD2 mRNA | CTD | PMID:23179753 and PMID:24383497 | PDZD2 | Human | valproic acid | decreases expression | ISO | Pdzd2 (Rattus norvegicus) | 6480464 | Valproic Acid results in decreased expression of PDZD2 mRNA | CTD | PMID:29427782 | PDZD2 | Human | valproic acid | affects splicing | ISO | Pdzd2 (Rattus norvegicus) | 6480464 | Valproic Acid affects the splicing of PDZD2 mRNA | CTD | PMID:29427782 | PDZD2 | Human | vancomycin | increases expression | ISO | Pdzd2 (Mus musculus) | 6480464 | Vancomycin results in increased expression of PDZD2 mRNA | CTD | PMID:18930951 | |